Case Report: Disseminated Strongyloidiasis in a Patient with COVID-19 | Zendy

Audun Lier | Zendy; Jessica Tuan | Zendy; Matthew W. Davis | Zendy; Nathan Paulson | Zendy; Dayna McManus | Zendy; Sheldon Campbell | Zendy; David R. Peaper | Zendy; Jeffrey Topal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Case Report: Disseminated Strongyloidiasis in a Patient with COVID-19

Author(s) -

Audun Lier,

Jessica Tuan,

Matthew W. Davis,

Nathan Paulson,

Dayna McManus,

Sheldon Campbell,

David R. Peaper,

Jeffrey Topal

Publication year - 2020

Publication title -

american journal of tropical medicine and hygiene

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.015

H-Index - 151

eISSN - 1476-1645

pISSN - 0002-9637

DOI - 10.4269/ajtmh.20-0699

Subject(s) - strongyloidiasis , strongyloides stercoralis , covid-19 , pandemic , tocilizumab , coinfection , strongyloides , medicine , immunology , virology , intensive care medicine , human immunodeficiency virus (hiv) , helminths , outbreak , rheumatoid arthritis , disease , infectious disease (medical specialty)

The SARS-CoV-2 virus has emerged and rapidly evolved into a current global pandemic. Although bacterial and fungal coinfections have been associated with COVID-19, little is known about parasitic infection. We report a case of a COVID-19 patient who developed disseminated strongyloidiasis following treatment with high-dose corticosteroids and tocilizumab. Screening for Strongyloides infection should be pursued in individuals with COVID-19 who originate from endemic regions before initiating immunosuppressive therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research